Skip to main content

Breadcrumb

  1. Home

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

First-in-human Study of SAR443579 Infusion in Male and Female Participants of at Least 12 Years of Age With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL) or High Risk-myelodysplasia (HR-MDS)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about First-in-human Study of SAR443579 Infusion in Male and Female Participants of at Least 12 Years of Age With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL) or High Risk-myelodysplasia (HR-MDS)

Cephea Early Feasibility Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Cephea Early Feasibility Study

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infecti

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infecti

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • …
  • Next page Next
  • Last page Last
Subscribe to